Knockout of the neurokinin 3 receptor enhances cognitive performance and alters behavioral responding to dopaminergic stimulation

Knockout of the neurokinin 3 receptor enhances cognitive performance and alters behavioral responding to dopaminergic stimulation

Show other versions (1)

Bibliographic Details
Main Authors:	Nordquist, R, Savignac, H, Pauly-Evers, M, Borroni, E, Glaentzlin, P, Bohrmann, B, Messer, J, Ozmen, L, Spooren, W
Format:	Conference item
Published:	2007

Similar Items

Knockout of the neurokinin 3 receptor enhances cognitive performance and alters behavioral responding to dopaminergic stimulation
by: Nordquist, R, et al.
Published: (2008)

Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice.
by: Nordquist, R, et al.
Published: (2008)

Cognitive performance in neurokinin 3 receptor knockout mice.
by: Nordquist, R, et al.
Published: (2008)

Capsaicin-Mediated Neurogenic Vasodilatation in Neurokinin-1, NK1, Receptor Knockout Mice
by: A. D. Grant, et al.
Published: (2001-01-01)

Structural insights into the activation of neurokinin 2 receptor by neurokinin A
by: Wenjing Sun, et al.
Published: (2022-07-01)

Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P
by: Amanda R. Burmeister, et al.
Published: (2017-12-01)

Neurokinin-2 receptor negatively modulates substance P responses by forming complex with Neurokinin-1 receptor
by: Lan Phuong Nguyen, et al.
Published: (2023-11-01)

Neurokinin-1 receptors on the afferents to the raphe
by: Hafizi, S, et al.
Published: (2005)

Neurokinin-1 receptors on the afferents to the raphe
by: Hafizi, S, et al.
Published: (2005)

The pharmacology of neurokinin receptors in addiction: prospects for therapy
by: Sandweiss AJ, et al.
Published: (2015-09-01)

Neurokinin receptors and their implications in various autoimmune diseases
by: Amrita Mishra, et al.
Published: (2021-01-01)

Neurokinin-1 receptor activation in globus pallidus
by: Lei Chen, et al.
Published: (2009-10-01)

Beyond incretins: targeting neurokinin receptors for obesity treatment
by: Doreen Thor, et al.
Published: (2025-01-01)

The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer
by: Marisa Rosso, et al.
Published: (2012-01-01)

Chronic antidepressant drug treatment does not alter neurokinin-1 receptor expression in the rat brain regions
by: Sartori, S, et al.
Published: (2001)

Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor
by: Duy-Khanh Dang, et al.
Published: (2018-02-01)

Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations.
by: Hafizi, S, et al.
Published: (2007)

Brain neurokinin-1 receptors in depression and interactions with the serotonin system
by: Hafizi, S
Published: (2009)

Erratum to “The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer”
by: Marisa Rosso
Published: (2012-01-01)

The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors
by: Julian Kolorz, et al.
Published: (2021-12-01)

Activation of Spinal Cholecystokinin and Neurokinin-1 Receptors Is Associated With the Attenuation of Intrathecal Morphine Analgesia Following Electroacupuncture Stimulation in Rats
by: Yohji Fukazawa, et al.
Published: (2007-01-01)

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
by: Noelia Granado, et al.
Published: (2011-06-01)

Neurokinin-1 Receptor Antagonist Treatment in Polymicrobial Sepsis: Molecular Insights
by: Akhil Hegde, et al.
Published: (2010-01-01)

Characteristics of Neurokinin-3 Receptor and Its Binding Sites by Mutational Analysis
by: Ishwar Atre, et al.
Published: (2021-09-01)

Neurokinin-1 receptor signalling impacts bone marrow repopulation efficiency.
by: Alexandra Berger, et al.
Published: (2013-01-01)

Decreased Brain Neurokinin-1 Receptor Availability in Chronic Tennis Elbow.
by: Clas Linnman, et al.
Published: (2016-01-01)

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
by: Sonja Ständer, et al.
Published: (2010-06-01)

Neurokinin receptors in the gastrointestinal muscle wall: cell distribution and possible roles
by: Vannucchi Maria Giuliana, et al.
Published: (2013-06-01)

Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation
by: Yuhan Wang, et al.
Published: (2017-12-01)

LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors.
by: Hinkle, K, et al.
Published: (2012)

<it>LRRK2</it> knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors
by: Hinkle Kelly M, et al.
Published: (2012-05-01)

FMRFa receptor stimulated Ca2+ signals alter the activity of flight modulating central dopaminergic neurons in Drosophila melanogaster.
by: Preethi Ravi, et al.
Published: (2018-08-01)

GPR54-dependent stimulation of luteinizing hormone secretion by neurokinin B in prepubertal rats.
by: Pasha Grachev, et al.
Published: (2012-01-01)

Neurokinin3 receptor modulation of the behavioral and neurochemical effects of cocaine in rats and monkeys.
by: Silva, M, et al.
Published: (2008)

ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET
by: Gardner, C, et al.
Published: (1994)

Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation.
by: Jones, S, et al.
Published: (2008)

Expression of Neurokinin B Receptor in the Gingival Squamous Cell Carcinoma Bone Microenvironment
by: Shoko Yoshida, et al.
Published: (2021-06-01)

Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
by: Melissa Conklin, et al.
Published: (2023-06-01)

Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists
by: Wenjing Sun, et al.
Published: (2023-06-01)

Expression of substance P and neurokinin-1 receptor in nasopharyngeal carcinoma and their clinical significance
by: ZHANG Yu, et al.
Published: (2020-07-01)